Glioma, Motor Cortex; Lesion, Supplementary Motor Area Syndrome
Conditions
Keywords
human, motor recovery, transcranial magnetic stimulation
Brief summary
The goal of this randomized clinical controlled trial is to learn about whether neuro-navigation repetitive transcranial magnetic stimulation (nrTMS) was useful to accelerate the recovery in patients with SMA syndrome after glioma resection. The main questions aim to answer: * Question 1: Whether the nrTMS was useful to accelerate the recovery of motor function back to the preoperative status in participants with SMA syndrome after glioma resection. * Question 2: Whether the nrTMS was useful to improve postoperative motor function in participants with SMA syndrome after glioma resection. Participants will continue to receive nrTMS treatment or nrTMS sham-treatment for 7 times on the 8th day after glioma resection to determine whether the TMS was helpful for exercise rehabilitation. The investigator will evaluate the effects of nrTMS treatment through the ratio of recovery of motor function and the time that was from the participants suffering SMA syndrome to totally recover the motor function to the status of motor function in pre-operation.
Detailed description
This study will use the 8-coil (Magstem, England, No.4150) and sham 8-coil (Magstem, England) The criteria of enrolled patients are： A. Inclusion time: from April 01 2023 to March 31 2025 (including the current month); B. Inpatients in neurosurgery oncology wards of Beijing Tiantan Hospital; C. Right-handed, age: 25-55 years old, tumor located in SMA, no previous treatment history of nervous system disease; D. The patient received wake-up surgery and applied direct cortical electrical stimulation during the operation to determine the location of the motor area; E. Postoperative pathology was low grade glioma; F. Can accept nrTMS rehabilitation treatment. The excluding criteria are: A. The tumor grows across the midline to the opposite side; B. When collecting rs-fMRI data, head movement exceeds 1mm and head deflection exceeds 1 °; C. The patient did not have SMA syndrome after operation; D. Vulnerable or special groups and protective measures, such as pregnant women.
Interventions
DEVICETMS stimulation treatment
Using the TMS treatment coli to stimulation with high frequency
DEVICETMS stimulation sham-treatment
Using the TMS sham-treatment coli to stimulation with high frequency
Sponsors
Beijing Neurosurgical Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Masking description
There are two stimulating colis with the same shape, color and touch. The one is able to stimulate, the other is able to sham-stimulate. All patients are randomly assigned to use one of the two coils for treatment. Except for the designer, all participant, care provider, investigator, and outcomes assessorthey don not know who used which coil to treatment.
Intervention model description
There are two groups of this study. The one is that the patients receive nrTMS stimulation with high-frequency on the thumb-related motor cortex on the lesional hemisphere. The other is that the patients receive nrTMS sham-stimulation with high-frequency on the thumb-related motor cortex on the lesional hemisphere.
Eligibility
Sex/Gender
ALL
Age
25 Years to 55 Years
Healthy volunteers
No
Inclusion criteria
* Inpatients in neurosurgery oncology wards of Beijing Tiantan Hospital * Right-handed, age: 25-55 years old * Tumor located in supplementary motor area * No previous treatment history of central nervous system disease * The patient received awaken craniotomy * Pathological diagnosis is low grade glioma * Volunteer to accept nrTMS treatment
Exclusion criteria
* The tumor grows across the midline to the opposite side * Regarding rs-fMRI data, head movement exceeds 1mm and head deflection exceeds 1 ° * The patient did not have SMA syndrome after operation * Vulnerable or special groups and protective measures, such as pregnant women
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Motor function totally recovering in evaluating with MRC (the UK Medical Research Council) muscle strength test | From the day of tumor resection to 3 months after tumor resection | The motor function recovers back to the status in pre-operation. The motor status means that the muscle strength muscle of upper limb that is controlled by lesional hemisphere. Moreover, the recovering back means that the muscle strength achieves at grade 5 (healthy grade). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Motor function improve in evaluating with MRC (the UK Medical Research Council) muscle strength test | From the day of tumor resection to 3 months after tumor resection | The motor function improves compared with the day of SMA syndrome occuring. The motor status means that the strength muscle of upper limb that is controlled by lesional hemisphere. Moreover, the motor imporvement means that the muscle strength is higher than the SMA syndrome occurring but does not achieve grade 5 (healthy grade). |
Countries
China
Contacts
Primary ContactShengyu Fang, MD
Backup ContactTao Jiang, MD
Outcome results
None listed